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Mutant prenyltransferase-like mitochondrial protein (PLMP)
and mitochondrial abnormalities in kd/kd mice.
Background. Mice that are homozygous for the kidney dis-
ease (kd) mutation are apparently healthy for the first 8 weeks
of life, but spontaneously develop a severe form of interstitial
nephritis that progresses to end-stage renal disease (ESRD) by
4 to 8 months of age. By testing for linkage to microsatellite
markers, we previously localized the kd gene to a YAC/BAC
contig.
Methods. The sequence of the entire critical region was ex-
amined, and candidate genes were identified. These candidate
genes were sequenced in both mutant (kd/kd) mice and nor-
mal controls. The phenotype was further characterized by im-
munohistochemistry and electron microscopy. Transgenic mice
were constructed that carried the wild-type allele of the prime
candidate gene, and this transgene was transferred to a kd/kd
background by breeding.
Results. We have obtained evidence that kd is a mutant allele
of a novel gene for a prenyltransferase-like mitochondrial pro-
tein (PLMP). This gene is alternatively spliced, with the larger
gene product having one domain that resembles transprenyl-
transferase and another that is similar to geranylgeranyl py-
rophosphate synthase. The smaller gene product includes only
the first domain. An antiserum to PLMP localizes to mitochon-
dria, and ultrastructural defects are present in the mitochondria
of renal tubular epithelial cells, and to a lesser extent, hepato-
cytes and heart cells from kd/kd mice. In a line of kd/kd mice
that carried the wild-type PLMP allele as a transgene, only 1
out of 13 animals expressed the disease by 120 days of age.
Conclusion. The kd allele codes for a novel protein that local-
izes to the mitochondria, and the kd/kd mouse has dysmorphic
mitochondria in the renal tubular epithelial cells. This mouse is
therefore a unique animal model for studying mechanisms that
lead to tubulointerstitial nephritis.
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A spontaneous mutation designated kidney disease
(kd) occurred in a CBA/CaH colony, and in the homozy-
gous condition produces interstitial nephritis leading to
end-stage renal failure [1]. Examination of kidneys at
early time-points reveals a mononuclear cell infiltrate
and tubular dilatation in cortical areas, which with time
expands throughout the entire kidney [2–4]. Histologic
features of this disease resemble human nephronoph-
thisis in some respects, but none of the mapped genes
for this entity are in positions that correspond to the re-
gion of mouse chromosome 10 in which kd maps [1, 5].
These include NPHP1 on 2q13 [6], NPHP2 on 9q22–31
[7], NPHP3 on 3q22 [8], and NPHP4 on 1p36 [9].
The evidence for an autoimmune component in the
phenotype of kd/kd mice is strong. An inflammatory re-
action can be observed in histologic sections of the dis-
eased kidneys [1–3]; the disease can be transferred by
bone marrow cells to lethally irradiated recipients; and
effector T cells can induce nephritis in this model [2].
However, we have recently shown that mice that are dou-
bly homozygous for kd and Rag-1− developed nephritis
as readily and as severely as the B6.kd/kd controls [10].
Mice with the Rag-1−/− genotype do not have functional
T or B cells, and the leukocytes infiltrating the kidneys of
the kd/kd,Rag-1−/− mice consisted of approximately 50%
macrophages and 50% natural killer (NK) cells. These
results suggested that the genetic defect in kd/kd mice is
intrinsic to the kidney, and that an immune response in-
volving either effector T cells or NK cells is a secondary
consequence of this initial defect.
We used a positional cloning approach to identify
the mutation. After analyzing the complete sequence
of a previously reported contig [5], and using reverse
transcription-polymerase chain reaction (RT-PCR) to
compare mutant and control samples, we identified a
missense mutation in one of the candidate genes. The
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sequence of the candidate gene suggested that the mu-
tant enzyme could affect coenzyme Q in the respiratory
pathway. Tissues from kd/kd mice, examined by electron
microscopy, revealed ultrastructural abnormalities in the
mitochondria of kidney, and to a lesser extent, liver and
heart cells of kd/kd mice. The phenotype of kd/kd mice
was rescued to a large extent by a BAC transgene that in-
cluded the genomic DNA for the first of two alternatively
spliced products of this prenyltransferase-like mitochon-
drial protein (PLMP) gene.
METHODS
Mouse genetics
All animal experiments were done in compliance with
federal and university regulations. The B6.CBACaH
(CAST)-kd/Upa (B6.kd/kd) strain was derived by mat-
ing a mouse carrying a recombinant kd haplotype [5]
with B6, and backcrossing to the B6 line [10]. Transgenic
lines carrying BAC inserts were generated by standard
procedures, by injecting purified DNA from the 256E1
BAC (Research Genetics, Huntsville, AL, USA) into (B6
X SJL)F1 eggs fertilized by (B6 X SJL)F1 males. Pups
identified to be positive for the transgene were grown
up and then mated with B6.kd/kd partners. Transgene-
positive progeny from that mating were mated with
B6.kd/kd partners to produce a second backcross gener-
ation with a transgene-positive, kd/kd genotype. In order
to evaluate the expression of the transgene, PCR prod-
ucts of the relevant region were sequenced after RNA
extraction from kd/kd, transgene-positive mice. Among
the transgenic lines that were generated, only one (line
G) expressed the wild-type transgene at a high level.
These mice were mated with one another, and the kd/kd,
transgene-positive mice were evaluated histologically af-
ter the age of 120 days. As a control, a similar line on the
same background that was vector-positive but did not ex-
press the transgene (line E) was also examined.
Protein expression and antiserum production
The normal PLMP gene product was expressed in
vitro by use of the PCR T7 TOPO TA Expression Kit
(Invitrogen, Carlsbad, CA, USA), using the PCR T7/
NT-TOPO vector, and then purified with the ProBond
purification system (Invitrogen). The HisG and Xpress
epitopes were removed by enterokinase. This product
was injected into Sprague-Dawley rats, and the antibody
generated was used for Western blotting and immunohis-
tology. The Western blotting was done by standard proce-
dures using tissue extracts separated by sodium dodecyl
sulfate (SDS) electrophoresis, transferring to Hybond-
N+ membranes (Amersham Pharmacia Biotech,
Buckinghamshire, UK), and incubation with antiserum
or control serum.
Sequencing and RT-PCR
The mouse sequence database was searched with BAC
end sequences that were known to map within the crit-
ical region for the kd gene [5]. RT-PCR was used to
amplify coding regions from kd/kd mice with respect to
numerous previously defined genes and expressed se-
quence tags (ESTs) that were identified within this re-
gion, and the sequences were compared with those in the
database. The forward primer that was used to identify
both the shorter and longer gene sequences described
in this report was ATGAGCCTCCGGCAGCTGCTG.
The reverse primer for the shorter product was TTAC
TTCATGTTGTCACTGCC, and for the longer prod-
uct, TTCAAGAAAATCTGGTCACAGC. Both RT-
PCR products were sequenced, and shown to be unique
sequences that mapped in the expected location of the
genome.
Histology and immunoperoxidase staining
The mice were sacrificed and examined histologically
at various ages. Representative kidneys from normal
C57BL/6 mice and B6.kd/kd mice were examined by im-
munoperoxidase using the anti-PLMP antibody or con-
trol IgG, as described [10]. B6.kd/kd kidneys were col-
lected prior to onset of interstitial disease (<50 days),
around the time of onset (75 to 100 days) and during ad-
vanced disease (>150 days).
Immunoelectron microscopy
Kidney, liver, and skeletal muscle were taken from con-
trol and diseased mice and fixed in 4% paraformaldehyde
with 0.1% glutaraldehyde in 0.1 mol/L sodium cacodylate
buffer, pH 7.4, overnight at 4◦C. Two separate protocols
were employed for each tissue. For a review of electron
microscopic immunoelectron microscopic protocols, see
Smith and Jarett [11]. Briefly, one group of tissue was per-
meablized with 0.2% saponin in 4% paraformaldehyde
for 1 hour. After 3 sodium cacodylate buffer washes, sam-
ples were treated for 1 hour with blocking buffer [1%
ovalbumin, 0.2% fish gelatin, in 0.1 mol/L phosphate-
buffered saline (PBS), pH 7.4] before incubation with
primary antibody (1:400 in PBS) overnight at 4◦C. After
three additional buffer washes, samples were dehydrated
in a graded ethanol series to 90% ethanol, infiltrated,
and embedded in LR White resin. A second group of
tissues was processed to LR White resin by similar tech-
niques, omitting the permeablization with saponin, and
the incubation with primary antibody. After polymeriza-
tion of both groups, thin sections were taken and picked
up on nickel grids. All further treatment of thin sections
was performed by floating the grids, section side down,
on 20 uL drops of reagent displayed on a clean parafilm
surface. For samples previously incubated with primary
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Fig. 1. Histologic sections (both hematoxylin and eosin 100×) from
a normal B6 mouse at 158 days of age (A) and a B6.kd/kd mouse at
the age of 116 days (B) showing moderately severe tubulointerstitial
nephritis (3+) with interstitial mononuclear cell infiltration and tubular
dilatation.
antibody, sections were treated with blocking buffer for
30 minutes at room temperature, and incubated with anti-
rat IgG conjugated to 10 nm colloidal gold particles (1:20
in PBS) overnight at 4◦C. Sections were then washed
twice in PBS, rinsed in dH2O, and counterstained with
1% uranyl acetate. Samples not previously exposed to
primary antibody were treated with blocking buffer for
1 hour at room temperature prior to incubation with pri-
mary antibody (1:500 in PBS) for 2 hours at room tem-
perature. After three Tris-buffered saline (TBS) washes,
sections were incubated with antirat IgG conjugated to
10 nm colloidal gold particles (1:40 in PBS) for 1 hour
at room temperature. After several buffer washes, sec-
tions were rinsed in dH2O and counterstained with uranyl
acetate. All sections were examined in a JEOL 100CX
electron microscope and digital images recorded with a
Hamamatsu camera system.
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Fig. 5. Immunoperoxidase staining of renal tubular epithelium in
B6.kd/kd kidneys using an anti-prenyltransferase-like mitochondrial
protein (PLMP) antibody. (A) Lack of staining of normal C57BL/6
kidney, at 286 days of age. (B) Lack of staining of B6.kd/kd mouse
kidney at 49 days of life. (C) Focal renal tubular staining for PLMP
(arrows) in a kidney from B6.kd/kd mouse at 91 days (around time of
onset of interstitial nephritis). (D) Lack of staining of kidney from (C)
with control IgG. (E) Extensive lack of staining using control IgG, rab-
bit antihorseradish peroxidase (HRP). (F) Lack of staining of kidney
tubular staining for PLMP in the kidney of a B6.kd/kd mouse at 177
days (cryostat sections, hematoxylin counterstain, original magnifica-
tions ×250).
Ultrastructural analysis
Kidney, liver, heart, and muscle tissue samples, taken
from control and diseased animals, were processed for
electron microscopic ultrastructural analyses. They were
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Fig. 2. Sequence of the mutated portion of the candidate gene, showing
the mutation at codon 117.
fixed in 2.5% glutaraldehyde and 2.0% paraformalde-
hyde in 0.1 mol/L sodium cacodylate buffer, pH 7.4,
overnight at 4◦C. After three sodium cacodylate buffer
washes, the samples were post-fixed with 2.0% osmium
tetroxide in 0.1 mol/L sodium cacodylate buffer for 1 hour
at 4◦C. After two additional sodium cacodylate washes
and one wash in dH2O, samples were stained en bloc with
2% aqueous uranyl acetate for 30 minutes at room tem-
perature. Samples were rinsed again in dH2O subsequent
to dehydration in a graded ethanol series, and infiltration
and embedding in Embed-812 (Electron Microscopy Sci-
ences, Fort Washington, PA, USA). All sections were ex-
amined in a JEOL 100CX electron microscope and digital
images recorded with a Hamamatsu camera system.
Evaluation of nephritis
Transgenic mice were evaluated for nephritis as pre-
viously reported [10]. Hematoxylin and eosin sections
were graded on a scale of 0 to 4+ by one observer (M.
Madaio) who was blinded with respect to the origin of the
specimens. Because mild symptoms are occasionally seen
in nonmutant controls, a mouse was considered positive
only if there was a score of 2+ with regard to the intersti-
tial compartment. This excludes mice in which there were
small pockets of 5 to 10 mononuclear cells.
RESULTS
The phenotype of the B6.kd/kd strain
The initial studies of this mutant made use of the origi-
nal CBA/CaH-kd line [1–3]. To our knowledge this strain
no longer exists, so we have utililized a congenic line
which was derived by transferring the kd allele, along
with closely linked microsatellite markers, to the B6 back-
ground [10]. Figure 1 demonstrates a histologic section
from the kidney of a B6.kd/kd mouse in comparison to
that of a B6 control. In Figure 1B, many of the tubules
are dilated so extensively that the magnification appears
to be greater than in Figure 1A, although they are both
100×. The section shown in Figure 1B, which is repre-
sentative of what we have observed in B6.kd/kd mice,
Table 1. The mutation occurred in a highly conserved region:
sequence of positions 116–119 in related proteins from various species
Species and enzyme Sequence
Mouse kd mutant protein VMLL
Mouse wild-type prenyltransferase-like VVLL
mitochondrial protein (PLMP)
Mouse transprenyltransferase VVLL
Human transprenyltransferase VVLL
Zebrafish transprenyltransferase IVIL
Drosophila transhexaprenyltransferase IVLL
Cyanophora paradoxa prenyltransferase IVLL
Cyanidium caldarium prenyltransferase IVLL
Synechocystis prenyltransferase IVLL
Porphyra purpura (Red alga) prenyltransferase IVLL
Arabidopsis thaliana prenyltransferase LVFL
does not differ significantly in the degree of interstitial
nephritis from those in previous reports that utilized the
CBA/CaH-kd line.
Identification of a mutant candidate gene
When the various candidate genes in the critical region
[5] were examined by amplifying the coding regions using
RT-PCR and sequencing the products from mutant and
control mice, a missense mutation was identified in one
of the candidates (GenBank # AK017329) in the DNA
from the original CBA/CaH-kd line. This mutation in-
volved a CG to TG substitution on the antisense strand,
which is consistent with the activity of a mutation hotspot
(Fig. 2). The genomic DNA of the candidate gene con-
sists of 8 exons, which are alternatively spliced to produce
two possible products. The shorter product has a domain
that is similar to transprenyltransferases from a number
of species, and the mutated residue is especially well con-
served (Table 1). The longer product includes most of
the residues in the first message, including the mutated
residue, in addition to a domain that is very similar to ger-
anylgeranyl pyrophosphate synthase (Fig. 3). All of exon
3 is included in the short product, with a stop codon in
exon 3b. Only part of exon 3 (3a) is in the longer product.
Identification of PLMP in kidney sections
A cDNA for the shorter candidate gene product was
used to produce the wild-type protein in a bacterial ex-
pression system, and an antiserum to this product was
generated in Sprague-Dawley rats. When this antiserum
was used for Western blotting, it was apparent that both
alternatively spliced gene products are expressed in the
kidneys of normal and kd/kd mice. One protein of ap-
proximately 92 kD was derived from the 1174 bp message,
and a smaller protein of approximately 65 kD was derived
from the message of 795 bp (Fig. 4). In both cases these
proteins are somewhat larger than what would be ex-
pected from the amino acid sequence, so there apparently
have been some posttranslational modifications. Control
Western blots were run using normal rat serum and rat
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Fig. 3. Exons of the prenyltransferase-like mitochondrial protein (PLMP) gene (A) and protein sequences of the two alternatively spliced products
of the kd allele (B and C). The substituted residue, encoded by exon 2, is shown in bold and underlined.
anti-PLMP serum incubated with the PLMP product ob-
tained from a bacterial expression system, and both were
negative (not shown). A subset of renal tubular epithe-
lial cells in the B6.kdkd but not B6 mouse showed more
strongly positive staining with the rat antibody (Fig. 5).
Localization of PLMP by immunoelectron microscopy
The same anti-PLMP antibody was then used for elec-
tron microscopy studies, with pre- and post-fixed im-
munogold techniques as detailed in the Methods section
[11]. Samples of kidney, liver, and skeletal muscle were
taken from B6 and B6.kd/kd mice and examined by both
techniques. Using these immunogold techniques, the liver
and skeletal muscle samples from B6 mice were indistin-
guishable from sections of the same tissue from B6.kd/kd
mice. Both tissues showed only an occasional gold parti-
cle, indicating the presence of the kd gene product, mostly
found on mitochondria (data not shown). The kidney
from B6 mice (Fig. 6A) appeared normal with an occa-
sional gold particle located mostly over mitochondria. In
contrast, the B6.kd/kd kidney had markedly increased
gold particles on mitochondria (Fig. 6B). These findings
demonstrate that PLMP was over-expressed in the mito-
chondria of kidney from the B6.kd/kd mice, and provide
further evidence that this defective gene product is re-
sponsible for the kidney disease.
Ultrastructural defects in mitochondria of kd/kd mice
Tissues used for immunoelectron microscopy do not
always demonstrate the level of preservation needed
for fine structural analysis, as the fixation procedures
are designed for preservation of antigenicity rather than
fine structure. Therefore, tissue samples of kidney, liver,
heart, and skeletal muscle were taken from control and
experimental animals and were prepared expressly for
fine structural analysis. The results of these examinations
demonstrate clear alterations in the ultrastructure of kid-
ney mitochondria from B6.kd/kd as compared to B6 cells
The major difference between the B6 and B6.kd/kd kid-
ney samples (Fig. 7A vs. Fig. 7B) is the complete absence
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Fig. 4. Results of various evaluation techniques. (A) Reverse
transcription-polymerase chain reaction (RT-PCR) using primers for
the shorter (lanes A and B) and longer (lanes C and D) alternatively
spliced gene products. Lanes A and C, B6; lanes B and D, B6.kdkd.
RNA was extracted from kidneys. (B) Western blot using kidney ex-
tracts and the rat antiserum against the shorter gene product. Lane A,
B6; lane B, B6.kd/kd.
of mitochondrial matrix granules in the latter tissue, com-
pared to their prevalent inclusions in mitochondria of B6
kidney tissue. Furthermore, cristae of the B6 kidney tis-
sue are more dilated than in the B6.kd/kd kidney tissue,
where they are compressed. The mitochondrial matrix ap-
pears less dense and more heterogeneous in the B6.kd/kd
tissue and in general the B6.kd/kd kidney mitochondria
are smaller and have a more angular appearance.
Some of the ultrastructural differences between the mi-
tochondria of B6 and B6.kd/kd kidney tissue are also seen
with liver mitochondria (Fig. 7C and D), including the
lack of matrix granules, less dense mitochondrial matrix,
and overall angular morphology. An especially interest-
ing difference is that the endoplasmic reticulum (arrow
heads in Fig. 7D) is often closely associated with the mi-
tochondria. Although the liver mitochondria of the dis-
eased mice have fine structural alterations similar to those
in the kidney, they do not have an increased quantity
of the gene product in their mitochondria. Some of the
same abnormalities that were seen in hepatocytes were
also seen in heart from kd/kd mice (not shown). In con-
trast to the results from the mitochondria from kidney
and liver tissue, samples of skeletal muscle from B6 and
B6.kd/kd mice were indistinguishable from each other
and appeared normal (not shown).
Phenotype rescue in BAC transgenic mice
To determine whether the correct candidate gene had
been identified, we attempted to rescue the phenotype
by generating BAC transgenics that carried the wild-type
candidate gene, PLMP. The BAC clone 256E1 includes
the entire genomic DNA of the first alternatively spliced
gene product, but not the second. All 15 of 15 control mice
of a transgenic line that included the vector sequence but
did not express the wild-type PLMP gene (line E), de-
veloped histologic evidence of disease by 120 days. In
contrast, only one of 13 of the kd/kd transgenic mice with
high expression of the wild-type transgene (line G), de-
veloped disease (Table 2).
DISCUSSION
The phenotype of the kd/kd mouse has been an inter-
esting focus of investigation for many years. Although
it was originally thought to resemble nephronophthisis
most closely [1], none of the mapped genes for that dis-
ease [6–9] are in positions that correspond to the region
of mouse chromosome 10 in which kd maps [1, 5]. The
immune response that occurs in these mice has been stud-
ied in a number of laboratories [2–4], but the extent to
which the pathology can be attributed to immunologic
damage is still unclear. We have recently demonstrated
that mice with the B6 background that are homozygous
for both Rag-1− and kd get an inflammatory interstitial
nephritis as readily and as severely as B6.kd/kd controls,
although it differs in its cellular composition. The infil-
trating leukocytes in this case are macrophages and NK
cells rather than macrophages and T cells [10], but the
pathologic mechanisms that are most relevant are yet to
be determined.
In order to define the primary event in the initiation of
this disease, we have used a positional cloning approach.
We have demonstrated that the kd allele has a missense
mutation in a novel gene that has one domain that re-
sembles transprenyltransferase, and another that is simi-
lar to geranylgeranyl pyrophosphate synthase. However,
genes for transprenyltransferase and geranylgeranyl
pyrophosphate synthase have previously been mapped to
mouse chromosomes 2 and 13, respectively, so the gene
products described in this report are different from those
that have been previously reported. Its greatest DNA
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Fig. 6. Immunoelectron microscopy labeling of prenyltransferase-like mitochondrial protein (PLMP) in B6 and B6.kd/kd mouse kidney samples.
The B6 mouse was 308 days old, and the B6.kd/kd mouse was 267 days of age. (A) Immunogold labeling of B6 mouse kidney, demonstrating
very few 10 nm gold particles (arrows), which are generally associated with mitochondria. (B) Immunogold labeling of B6.kd/kd mouse kidney
demonstrating a greatly increased number of gold particles associated with mitochondria. The increase in the number of gold particles indicates an
increased level of PLMP present in the B6.kd/kd kidney mitochondria (scale bars, 500 nm).
sequence homology is with a human gene that is known
in the databases as “candidate tumor suppressor protein”
(NM 020381.2), which to our knowledge has not been de-
scribed in the literature. When the protein sequences are
compared, its greatest homology is with geranylgeranyl
pyrophosphate synthases of various species, in a clus-
ter of orthologous groups (COG) of highly conserved
enzymes (COG0142). This gene has extensive similarity
(85.7% alignment) with the IspA gene of Escherichia coli,
which has farnesyl diphosphate (FPP) synthase activity.
Hexaprenylpyrophosphate synthase isolated from mito-
chondria of yeast is a member of the same COG, and a
strain with a mutation in this gene is deficient in coenzyme
Q [12].
A BAC which included the genomic DNA for the first
splice product was used to construct a transgenic line, and
this transgene rescued the phenotype in 12 out of 13 kd/kd
mice. In mice that had the same genetic background but
did not express the transgene, 15/15 developed nephritis
(Table 1). The difference is highly significant (X2 = 24;
P < 0.0001). That the phenotype was rescued in only 92%
of the animals could be explained by the fact that these
mice had two copies of the mutant kd gene and only one
copy of the wild-type allele. A second possibility is that
expression of both of the alternatively-spliced gene prod-
ucts may be needed for an entirely normal phenotype.
The sequence of this PLMP, as described in this report,
suggests that it is one of the enzymes involved in preny-
lation [13]. How many target molecules are affected by
this enzyme is not known, but by comparison to the yeast
mutant [12], we suggest that coenzyme Q may be one
of them. Because of that possibility, and the fact that
antibodies to PLMP localized to mitochondria (Fig. 6),
we examined mitochondria from kd/kd mice by electron
microscopy. Sections optimized for ultrastructural detail
demonstrated apparently defective mitochondria in both
kidney and liver of B6.kdkd mice (Fig. 7) and, to some
extent, in heart (not shown). There is an apparent corre-
lation between the mitochondrial changes and increased
gene product in kidney tissue with kidney disease, which
could represent compensation for a defective enzyme.
This increase, however, may be highly localized, as there
were no obvious increases in the amount of gene prod-
uct produced when whole kidney extracts were studied
by RT-PCR or Western blotting (Fig. 4). The occurrence
of an immune response in kd/kd mice that is directed
to a kidney antigen is clearly relevant [4]. An immune
response that is secondary to some other initial defect
is consistent with what has been observed with some
other autoimmune diseases, such as systemic lupus ery-
thematosis [14]. It remains to be determined why a mi-
tochondrial defect in renal tubular epithelium leads to
an immune response, whereas a similar defect in liver
or heart mitochondria apparently does not. We specu-
late that the differences in energy requirements between
tubular cells vs. hepatocytes or heart cells may differen-
tially affect cell stability and immunogenicity. Because of
the high rate of tubular transport in renal epithelia, they
are very dependent on oxygen consumption for energy
metabolism [15]. Liver cells, on the other hand, have alter-
native energy sources at low levels of oxygen supply [16].
These differences may hypothetically explain the relative
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Fig. 7. Ultrastructural analyses of mitochondria from B6 and B6.kd/kd mouse kidney and liver. (A) Electron micrograph of mitochondria from
B6 mouse kidney. Many normal mitochondrial matrix granules are seen (large arrow), as well as well-defined cristae, which are moderately dilated
(small arrow). The matrix is homogenous and the overall morphology is smooth and generally oblong. (B) Electron micrograph of mitochondria
from B6.kd/kd mouse kidney demonstrating a lack of normal mitochondrial inclusions. In addition, the cristae (small arrow) are compressed, and
the matrix is pale and granular. The overall morphology of the B6.kd/kd mitochondria appears smaller and more angular than mitochondria from
B6 mice. (C) Electron micrograph for mitochondria from B6 mouse liver demonstrating normal matrix granules (large arrow), and clearly defined,
moderately dilated cristae (small arrow). Endoplasmic reticulum (arrow heads) is often closely associated with the mitochondria. The mitochondrial
matrix is homogenous and moderately dense. d, Electron micrograph of mitochondria from B6.kd/kd liver demonstrating characteristics similar
to those of B6.kd/kd kidney mitochondria. There is an absence of normal matrix granules, and the matrix is paler and more granular than that
of B6 mouse liver mitochondria. The cristae (small arrow) seem less affected and appear near normal. The overall mitochondrial morphology
again appears generally more angular, but perhaps less so than in B6.kd/kd mouse kidney samples. The endoplasmic reticulum (arrow heads) often
appears to completely surround the mitochondria (scale bars, 500 nm).
tissue sensitivity of nephrons with PLMP mutations com-
pared to other tissues. In this regard, there is evidence
that apoptosis occurs in renal tubular epithelial cells of
kd/kd homozygotes before leukocyte infiltration can be
observed [10]. Apoptosis leads to externalization of sig-
nal molecules such as phosphatidylserine, which can be
recognized by macrophages [17] and NK cells [18]. The
immune response that is generated in the kd/kd mouse
after apoptosis of renal tubular epithelium can involve
either effector T cells or NK cells [10].
We suggest that the human disease with the greatest
similarity to this mouse model is represented by several
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Table 2. Phenotypes of control and kd/kd mice at >120 days of age
with or without expression of a wild-type transgene
Negative Positive
B6 12 0
B6.kd/kd 3 34
Line Ea 0 15
Line Ga 12 1
aLine E and line G both have a mixed genetic background from B6 and 129/J.
Both have the kd/kd genotype, and both are positive for the vector used to
construct the transgene for the candidate gene. Line G expresses the transgenic
wild-type allele of the candidate gene, but line E does not.
patients with tubulointerstitial nephritis who proved to
have deletions or mutations in their mitochondrial DNA
[19, 20]. In those cases the defects involved mitochondrial
genes rather than a nuclear gene such as kd, and the symp-
toms were not identical to those of kd/kd mice. However,
the similarities are quite interesting. All of these patients
started life in an apparent state of health, but at some
point developed a chronic tubulointerstitial nephritis. Ul-
trastructural analysis in all cases revealed abnormalities
in the mitochondria of renal tubular epithelial cells. The
kd/kd mouse may be a useful model, not only for study-
ing the physiologic role of PLMP, but for recognizing the
molecular defect in a number of human conditions that
have not been fully characterized.
CONCLUSION
These results demonstrate that the kd/kd mouse has a
mutation in a novel PLMP. Mitochondria in mutant mice
have structural abnormalities in renal tubular epithelium,
and to a lesser extent, in liver and heart. Evidence sug-
gests that apoptosis occurs in the renal tubular epithe-
lium, and this leads to an autoimmune response.
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